MYRTLE BEACH, SC (WMBF) - Get ready for two days filled with fun! Come along with us for everything you need to know about the 8th Annual Myrtle Beach Kite Festival. It’s happening on October 11-12 ...
Don’t expect to see bolts sticking out of Jacob Elordi‘s head. The new trailer for Guillermo del Toro‘s Frankenstein, which hits select theaters Oct. 17 before streaming on Netflix Nov. 7, finally ...
NUMBERS. GOOD LUCK. NOW YOU MIGHT WANT TO KEEP YOUR EYES TO THE SKIES. OF COURSE, MILWAUKEE’S LAKEFRONT THIS MORNING. VAN MCNEIL JOINS US LIVE FROM VETERANS PARK, WHERE THE FRANK MORRIS INTERNATIONAL ...
Gilead Sciences has become the latest pharma to strengthen its in vivo cell therapy credentials this year, paying $350 million for CAR-T developer Interius BioTherapeutics. Integrating Interius into ...
A parent filed a book challenge to have “The Kite Runner” removed from Wake County high schools. North Carolina’s largest school system has rejected a parent’s request to remove the book “The Kite ...
AI-generated summary reviewed by our newsroom. Read our AI Policy. Wake County school board panel voted 3-0 to retain 'The Kite Runner' in curriculum. Parent challenge cited graphic themes, but review ...
Wake County school board panel voted 3-0 to retain 'The Kite Runner' in curriculum. Parent challenge cited graphic themes, but review committee pointed to educational value. 'The Kite Runner' ranked ...
Horror Shows Alien: Earth team says the new show’s Xenomorph is "an animal in an ecosystem" with other "predatory" creatures, and explains the subtle design differences Horror Shows Alien: Earth ...
This year, Lincoln City will celebrate its 40th annual summer kite festival and its 45th annual fall kite festival. The small Oregon coast town’s title as the self-proclaimed “Kite Capital of the ...
A Wake County school committee has rejected a parent’s request to remove the book “The Kite Runner” from the high school English curriculum. “The Kite Runner” is an award-winning but frequently ...
Kite Pharma’s bicistronic CAR T-cell therapy hit the main goal of a phase 1a trial, with zero dose-limiting toxicities (DLTs) occurring in patients with advanced B-cell lymphoma (BCL). The therapy was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback